Alx Oncology Holdings (ALXO) Preferred Dividend Payments (2019 - 2020)
Alx Oncology Holdings (ALXO) reported Preferred Dividend Payments of $578000.0 for Q3 2020, down 46.03% on a YoY basis from $1.1 million in Q4 2019, and down 78.11% sequentially from $2.6 million in Q2 2020.
Alx Oncology Holdings (ALXO) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Alx Oncology Holdings (ALXO) has 2 years of Preferred Dividend Payments data on file, last reported at $578000.0 in Q3 2020.
- For the quarter ending Q3 2020, Preferred Dividend Payments fell 46.03% year-over-year to $578000.0; the trailing twelve-month figure through Dec 2020 stood at $5.2 million (changed N/A YoY), and the FY2020 full-year result was $5.2 million, up 29.15% from the prior year.
- Preferred Dividend Payments slipped to $578000.0 in Q3 2020, from $2.6 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q2 2020 to a low of $578000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 578,000.00 |
| Jun 30, 2020 | 2.64 Mn |
| Mar 31, 2020 | 1.98 Mn |
| Dec 31, 2019 | 1.07 Mn |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 981,000.00 |